Regulatory S16 Ep43: FDA Approval Insights: Rucaparib for BRCA Mutation-Associated mCRPC: With David Morris, MD, FACS; and Alan H. Bryce, MD OncLive PodcastWelcome to OncLive On Air !RegulatoryOncologyRead full story pharminent March 31, 2026 (Last updated: April 1, 2026) OncLive Podcast Welcome to OncLive On Air ! RegulatoryOncologyRead full story Post navigation Previous: Novo hits back at rivals with cut-price Wegovy subscriptionsNext: NHS to offer Wegovy to a million more people in England Related Stories Regulatory Third Circuit Affirms Denial of Stelara Biosimilar Injunction pharminent May 11, 2026 Regulatory Partner’s Bizengri cleared by FDA for ultra-rare cancer days after winning priority voucher pharminent May 11, 2026 Regulatory BMS’ Sotyktu secures EC approval for psoriatic arthritis pharminent May 11, 2026
